SLCO1B1 and Alzheimer disease: In our future research, we intend to investigate the role of OATPs in AD progression and drug treatment by examining the changes of Aβ1-42 expression in blood, liver and brain tissues of AD mice with knockout of Oatp2 or Oatp1a4 genes and drug interventions, and by observing changes in disease symptoms.